Inactive Instrument

Calendar Protalix Biotherapeutics Inc TEL AVIV STOCK EXCHANGE

Equities

US74365A1016

Chart calendar Protalix Biotherapeutics Inc

fa5103c16.KFFRPKdYyrLTdyqkTopr3mUwHn-NbAMSkGcohEUSX-U.emU_UJQR_oenFhLjPfA9sxFCVyrIH3Ag-FIZsSJED5ZNKzxaijOTwoARSQ~05e4193cc6816c331dcb441174c0ae13

Upcoming events on Protalix Biotherapeutics Inc

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-11 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on Protalix Biotherapeutics Inc

2024-03-14 08:30 am Q4 2023 Earnings Call
2024-03-14 06:50 am Q4 2023 Earnings Release
2024-02-26 01:00 pm BIO CEO & Investor Conference
2023-11-06 08:30 am Q3 2023 Earnings Call
2023-11-06 06:50 am Q3 2023 Earnings Release
2023-09-13 03:00 pm H.C. Wainwright Global Investment Conference
2023-08-09 03:30 pm Canaccord Genuity Growth Conference
2023-08-07 08:30 am Q2 2023 Earnings Call
2023-08-07 06:50 am Q2 2023 Earnings Release
2023-06-28 08:30 am Annual General Meeting
2023-06-27 08:00 am Investor Meeting
2023-05-04 08:30 am Q1 2023 Earnings Call
2023-05-04 06:50 am Q1 2023 Earnings Release
2023-02-27 08:30 am Q4 2022 Earnings Call
2023-02-27 06:50 am Q4 2022 Earnings Release
2023-02-21 WORLD Symposium
2022-12-05 08:30 am Investor Meeting - Key Opinion Leader
2022-11-14 08:30 am Q3 2022 Earnings Call
2022-11-14 06:50 am Q3 2022 Earnings Release
2022-09-14 11:00 am H.C. Wainwright Global Investment Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
15,9
16,5
-3.61%
16,2
35,1
-53.76%
38,4
37,6
2.02%
47,6
45,1
5.53%
65,5
64,0
2.41%

74,1

EBITDA
Million USD
Released
Forecast
Spread
-9,10
-18,7
51.34%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-10,7
-20,4
47.47%
2,71
-1,44
288.06%
-20,5
-18,5
-10.83%
-13,0
-18,2
28.44%
10,5
11,5
-9.12%

20,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-18,3
-28,0
34.73%
-6,52
-10,0
34.98%
-27,6
-26,0
-5.99%
-14,4
-18,8
23.43%
8,57
9,56
-10.41%

17,7

Net income
Million USD
Released
Forecast
Spread
-18,3
-28,0
34.73%
-6,52
-10,0
34.98%
-27,6
-26,0
-5.99%
-14,9
-18,8
20.61%
8,31
8,12
2.31%

17,7

EPS
USD
Released
Forecast
Spread
-1,23
-1,88
34.57%
-0,22
-0,34
34.33%
-0,62
-0,59
-5.08%
-0,31
-0,39
20.51%
0,09
0,11
-14.29%

0,21

Announcement Date12/03/2030/03/2131/03/2227/02/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
8,55
7,79
9.74%



8,75
2,68
227.21%
14,2
5,70
149.04%
8,62
6,12
40.8%



35,1
10,2
243.13%
10,3
7,64
35.41%
10,5
8,15
28.73%

9,20


8,90


10,5


21,6

EBIT
Million USD
Released
Forecast
Spread
-5,71
-3,71
-53.93%



-5,52
-8,72
36.62%
-3,13
-7,38
57.67%
-2,50
-7,67
67.45%



20,4
-1,82
1223.27%
-1,89
-3,77
49.89%
-5,62
-1,57
-257.19%












Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,67
-5,11
-30.55%



-5,33
-8,67
38.44%
-3,57
-7,33
51.36%
-3,21
-7,62
57.85%



19,6
-2,47
896.07%
-1,72
-4,75
63.82%
-6,43
-1,87
-243.27%












Net income
Million USD
Released
Forecast
Spread
-6,67
-5,11
-30.55%
-2,29


-5,33
-8,67
38.44%
-3,57
-7,33
51.36%
-3,74
-7,62
50.89%
-3,13


19,3
-2,47
883.59%
-1,85
-4,75
61.02%
-6,04
-1,87
-222.86%












EPS
USD
Released
Forecast
Spread
-0,14
-0,11
-27.27%
-0,05


-0,11
-0,18
38.89%
-0,07
-0,15
53.33%
-0,07
-0,15
53.33%
-0,05


0,21
-0,04
625%
-0,03
-0,07
57.14%
-0,07
-0,03
-180%

-0,02


-0,02


0,00


0,13

Announcement Date31/03/2216/05/2215/08/2214/11/2227/02/2304/05/2307/08/2306/11/2314/03/24----
  1. Stock Market
  2. Equities
  3. PLX Stock
  4. Stock
  5. Calendar Protalix Biotherapeutics Inc